| Dr Omayra M Quijano-vega, MD | |
|
1667 North Clyde Morris Blvd, Suite 2, Daytona Beach, FL 32117 | |
| (434) 248-7508 | |
| Not Available |
| Full Name | Dr Omayra M Quijano-vega |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | 1667 North Clyde Morris Blvd, Daytona Beach, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619032174 | NPI | - | NPPES |
| 1619032174 | Other | FL | TRICARE |
| 14E4C | Other | FL | BCBS |
| Entity Name | Nautilus Health Care Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912013558 PECOS PAC ID: 5991604852 Enrollment ID: O20040108000803 |
News Archive
Officials in Connecticut say insurers and families should pick up more bills for mental and developmental health services. In other news, California officials release details for new department of state hospitals and Colorado gets a new assessment of mental health services.
An antibacterial peptide developed by Laszlo Otvos, a research professor of biology in Temple's College of Science and Technology, looks to be a highly-effective therapy against infections in burn or blast wounds suffered by soldiers.
Through the publication of its Consensus Statement on the Management of High Blood Pressure in Blacks in this week's issue of Hypertension, ISHIB today released new recommendations recognizing that high blood pressure among African Americans is a severe health problem. The consensus statement suggests that treatment should start sooner and be more aggressive among African Americans.
Gilead Sciences, Inc. today announced that its head-to-head Phase III clinical trial of Cayston (aztreonam for inhalation solution) versus tobramycin inhalation solution in cystic fibrosis patients with Pseudomonas aeruginosa achieved one of its co-primary endpoints of non-inferiority for mean percent change in forced expiratory volume in one second (FEV1) percent predicted after 28 days of treatment.
Almost three quarters (72%) of women with Rheumatoid Arthritis suffer pain daily, despite the fact that three quarters (75%) receive pain relief medication, according to a new study presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy. Furthermore the physical pain appears to affect women to such an extent that it impacts negatively on emotional and social aspects of their lives.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Omayra M Quijano-vega, MD 8 Edwin Ln, Palm Coast, FL 32164-6357 Ph: () - | Dr Omayra M Quijano-vega, MD 1667 North Clyde Morris Blvd, Suite 2, Daytona Beach, FL 32117 Ph: (434) 248-7508 |
News Archive
Officials in Connecticut say insurers and families should pick up more bills for mental and developmental health services. In other news, California officials release details for new department of state hospitals and Colorado gets a new assessment of mental health services.
An antibacterial peptide developed by Laszlo Otvos, a research professor of biology in Temple's College of Science and Technology, looks to be a highly-effective therapy against infections in burn or blast wounds suffered by soldiers.
Through the publication of its Consensus Statement on the Management of High Blood Pressure in Blacks in this week's issue of Hypertension, ISHIB today released new recommendations recognizing that high blood pressure among African Americans is a severe health problem. The consensus statement suggests that treatment should start sooner and be more aggressive among African Americans.
Gilead Sciences, Inc. today announced that its head-to-head Phase III clinical trial of Cayston (aztreonam for inhalation solution) versus tobramycin inhalation solution in cystic fibrosis patients with Pseudomonas aeruginosa achieved one of its co-primary endpoints of non-inferiority for mean percent change in forced expiratory volume in one second (FEV1) percent predicted after 28 days of treatment.
Almost three quarters (72%) of women with Rheumatoid Arthritis suffer pain daily, despite the fact that three quarters (75%) receive pain relief medication, according to a new study presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy. Furthermore the physical pain appears to affect women to such an extent that it impacts negatively on emotional and social aspects of their lives.
› Verified 6 days ago
Dr. Richard Carl Weiss, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 303 N Clyde Morris Blvd, Halifax Regional Oncology Center, Daytona Beach, FL 32114 Phone: 386-254-4212 Fax: 386-254-4214 | |
Dhrumil Vijaykumar Patel, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 301 Memorial Medical Pkwy, Daytona Beach, FL 32117 Phone: 386-231-1091 Fax: 386-231-1092 | |
Alexandra Crossman, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 303 N Clyde Morris Blvd, Daytona Beach, FL 32114 Phone: 386-589-5741 | |
Dr. Vinicius Costa Diniz Domingues, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 709 N Clyde Morris Blvd, Daytona Beach, FL 32114 Phone: 347-543-1232 Fax: 347-543-1232 | |
Dr. David Scott Weinreich, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 731 N Clyde Morris Blvd, Daytona Beach, FL 32114 Phone: 386-257-1626 Fax: 866-899-3686 | |
Dr. Nashwa Marie Wahba, DO Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 810 Wildwood St, Suite 1, Daytona Beach, FL 32117 Phone: 386-258-7100 Fax: 386-253-1843 | |
Ms. Delinda Demita Wills, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 303 N Clyde Morris Blvd., Halifax Health Medical Center, Daytona Beach, FL 32114 Phone: 386-254-4152 Fax: 386-254-4315 |